The role of NIH in drug development innovation and its impact on patient access proceedings of a workshop

To explore the role of the National Institutes of Health (NIH) in innovative drug development and its impact on patient access, the Board on Health Care Services and the Board on Health Sciences Policy of the National Academies jointly hosted a public workshop on July 24-25, 2019, in Washington, DC....

Full description

Bibliographic Details
Main Author: Amankwah, Francis
Corporate Authors: National Academies of Sciences, Engineering, and Medicine (U.S.) Board on Health Care Services, National Academies of Sciences, Engineering, and Medicine (U.S.) Board on Health Sciences Policy, Workshop on the Role of NIH in Drug Development Innovation and Its Impact on Patient Access (2019, Washington, D.C.)
Other Authors: Andrada, Alexandra ([rapporteur]), Nass, Sharyl J. ([rapporteur]), Wizemann, Theresa M. ([rapporteur])
Format: eBook
Language:English
Published: Washington, DC National Academies Press [2020], 2020
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Description
Summary:To explore the role of the National Institutes of Health (NIH) in innovative drug development and its impact on patient access, the Board on Health Care Services and the Board on Health Sciences Policy of the National Academies jointly hosted a public workshop on July 24-25, 2019, in Washington, DC. Workshop speakers and participants discussed the ways in which federal investments in biomedical research are translated into innovative therapies and considered approaches to ensure that the public has affordable access to the resulting new drugs. This publication summarizes the presentations and discussions from the workshop
Physical Description:1 PDF file (xvi, 85 pages) illustrations
ISBN:9780309498487
0309498481